111 related articles for article (PubMed ID: 21368613)
1. F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma.
Shahani S; Ahmad A; Barakat FH; Chuang HH; Fowler NH; Myers JN; Stava C; Habra MA
Clin Nucl Med; 2011 Apr; 36(4):317-9. PubMed ID: 21368613
[No Abstract] [Full Text] [Related]
2. Detection of thyroid plasmacytoma by F-18 FDG PET/CT imaging.
Ozkan E; Tokmak E; Kir KM
Clin Nucl Med; 2008 Apr; 33(4):292-3. PubMed ID: 18356675
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
4. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
5. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
[TBL] [Abstract][Full Text] [Related]
7. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Makis W; Hickeson M; Novales-Diaz JA
Clin Nucl Med; 2010 Nov; 35(11):879-81. PubMed ID: 20940548
[No Abstract] [Full Text] [Related]
8. Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT.
Bertagna F; Sobic-Saranovic D; Obradovic V; Artiko V; Giubbini R; Alavi A
Hell J Nucl Med; 2009; 12(1):63. PubMed ID: 19330187
[No Abstract] [Full Text] [Related]
9. Solitary extramedullary plasmacytoma of the parotid gland imaged with 18F-FDG PET/CT.
Alabed YZ; Rakheja R; Laufer J
Clin Nucl Med; 2014 Jun; 39(6):549-50. PubMed ID: 24152625
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation.
Iagaru A; Mari C; Segall G
Clin Nucl Med; 2006 May; 31(5):279-80. PubMed ID: 16622337
[No Abstract] [Full Text] [Related]
12. Interesting image. Assessment of plasmablastic lymphoma by F-18 FDG PET/CT: case report.
Cazaentre T; Sanhes L; Laurent G; Costa K; Vallantin X; Pascal-Ortiz D
Clin Nucl Med; 2010 Nov; 35(11):882-3. PubMed ID: 20940549
[No Abstract] [Full Text] [Related]
13. 18F-FDG PET scanning in pulmonary amyloidosis.
Baqir M; Lowe V; Yi ES; Ryu JH
J Nucl Med; 2014 Apr; 55(4):565-8. PubMed ID: 24556593
[TBL] [Abstract][Full Text] [Related]
14. A low F-18 FDG uptake in the nasopharynx plasmacytoma detected by FDG PET/CT.
Dong MJ; Liu ZF; Wang GL; Zhao K; Sun ML; Wang HT; Yang SY
Clin Nucl Med; 2011 Nov; 36(11):1053-5. PubMed ID: 21975405
[No Abstract] [Full Text] [Related]
15. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
16. A rare presentation of myocardial plasmacytoma assessed by FDG PET/CT.
Tong AK; Mann KP; Schuster DM; Yan X
Clin Nucl Med; 2014 Jul; 39(7):643-5. PubMed ID: 24662655
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
18. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
19. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue.
Bertagna F; Giubbini R
Ann Nucl Med; 2011 Feb; 25(2):151-2. PubMed ID: 21104345
[No Abstract] [Full Text] [Related]
20. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Trybek T; Kowalska A; Lesiak J; Młynarczyk J
Nucl Med Rev Cent East Eur; 2014; 17(2):87-93. PubMed ID: 25088108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
